Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,253,000
-
Total 13F shares
-
25,838,571
-
Share change
-
-12,284
-
Total reported value
-
$325,371,521
-
Price per share
-
$12.60
-
Number of holders
-
90
-
Value change
-
-$304,837
-
Number of buys
-
29
-
Number of sells
-
47
Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q4 2017
As of 31 Dec 2017,
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,838,571 shares.
The largest 10 holders included
NWQ Investment Management Company, LLC, FRANKLIN RESOURCES INC, WYNNEFIELD CAPITAL INC, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., Vanguard Group Inc, ROYCE & ASSOCIATES LP, HEARTLAND ADVISORS INC, ROYAL BANK OF CANADA, and THOMSON HORSTMANN & BRYANT INC.
This page lists
90
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.